博雅生物：董事暨总裁任辉辞任

Core Viewpoint - Ren Hui has resigned from his positions as a director, member of the Strategy and ESG Committee, president, and legal representative of Boya Bio (300294) due to work-related changes, and this resignation will not affect the company's normal production operations [1] Group 1 - Ren Hui's resignation will not impact the company's normal production operations [1] - As of the announcement date, Ren Hui does not hold any shares in the company [1] - There are no unfulfilled commitments that Ren Hui is obligated to fulfill [1]